Arctic Bioscience AS (OSL: ABS)
Norway
· Delayed Price · Currency is NOK 2.080
-0.060 (-2.80%)
Nov 21, 2024, 4:25 PM CET
Arctic Bioscience AS Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 19.83 | 79.6 | 144.15 | 227.36 | 12.6 | 23.41 | Upgrade
|
| Cash & Short-Term Investments | 19.83 | 79.6 | 144.15 | 227.36 | 12.6 | 23.41 | Upgrade
|
| Cash Growth | -82.57% | -44.78% | -36.60% | 1704.45% | -46.18% | 2785.01% | Upgrade
|
| Accounts Receivable | 11.37 | 9.57 | 13.48 | 7.7 | 11.01 | 11.71 | Upgrade
|
| Other Receivables | 12.92 | 11.19 | 5.24 | 3.34 | 2.78 | 0.98 | Upgrade
|
| Receivables | 24.29 | 20.76 | 18.71 | 11.05 | 13.78 | 12.68 | Upgrade
|
| Inventory | 30.63 | 32.79 | 35.46 | 28.53 | 26.25 | 17.46 | Upgrade
|
| Restricted Cash | - | - | - | - | - | 0.58 | Upgrade
|
| Total Current Assets | 74.75 | 133.15 | 198.33 | 266.93 | 52.63 | 54.14 | Upgrade
|
| Property, Plant & Equipment | 25.61 | 26.44 | 22.33 | 15.99 | 6.36 | 3.14 | Upgrade
|
| Goodwill | 2.23 | 2.53 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 1.66 | 1.78 | 2.14 | 2.33 | 2.3 | 1.9 | Upgrade
|
| Long-Term Deferred Charges | 168.96 | 136.35 | 104.9 | 56.22 | 31.9 | 23.29 | Upgrade
|
| Other Long-Term Assets | - | - | -0 | - | - | 0 | Upgrade
|
| Total Assets | 273.21 | 300.25 | 327.7 | 341.47 | 93.2 | 82.47 | Upgrade
|
| Accounts Payable | 19.27 | 18.38 | 18.25 | 8.36 | 9.93 | 6.47 | Upgrade
|
| Accrued Expenses | 17.08 | 21.27 | 22.17 | 12.56 | 10.87 | 4.94 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 0 | 1.88 | - | Upgrade
|
| Other Current Liabilities | - | - | - | -0 | - | 0.01 | Upgrade
|
| Total Current Liabilities | 36.35 | 39.65 | 40.42 | 20.92 | 22.68 | 11.41 | Upgrade
|
| Long-Term Debt | - | - | - | - | 6.58 | 7.16 | Upgrade
|
| Long-Term Leases | 1.77 | 2.05 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0 | Upgrade
|
| Total Liabilities | 38.12 | 41.69 | 40.42 | 20.92 | 29.26 | 18.57 | Upgrade
|
| Common Stock | 2.54 | 2.54 | 2.44 | 2.43 | 1.29 | 1.29 | Upgrade
|
| Additional Paid-In Capital | 232.56 | 256.02 | 284.84 | 318.12 | 40.01 | 62.61 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | 22.64 | - | Upgrade
|
| Shareholders' Equity | 235.09 | 258.56 | 287.28 | 320.55 | 63.94 | 63.9 | Upgrade
|
| Total Liabilities & Equity | 273.21 | 300.25 | 327.7 | 341.47 | 93.2 | 82.47 | Upgrade
|
| Total Debt | 1.77 | 2.05 | - | 0 | 8.46 | 7.16 | Upgrade
|
| Net Cash (Debt) | 18.06 | 77.55 | 144.15 | 227.36 | 4.14 | 16.25 | Upgrade
|
| Net Cash Growth | -83.52% | -46.20% | -36.60% | 5385.57% | -74.50% | - | Upgrade
|
| Net Cash Per Share | 0.71 | 3.05 | 5.89 | 9.34 | 0.30 | - | Upgrade
|
| Filing Date Shares Outstanding | 25.37 | 25.37 | 24.46 | 24.3 | 13.88 | - | Upgrade
|
| Total Common Shares Outstanding | 25.37 | 25.37 | 24.46 | 24.3 | 13.88 | - | Upgrade
|
| Working Capital | 38.4 | 93.51 | 157.9 | 246.01 | 29.95 | 42.73 | Upgrade
|
| Book Value Per Share | 9.27 | 10.19 | 11.75 | 13.19 | 4.61 | - | Upgrade
|
| Tangible Book Value | 231.21 | 254.25 | 285.14 | 318.23 | 61.63 | 62 | Upgrade
|
| Tangible Book Value Per Share | 9.11 | 10.02 | 11.66 | 13.10 | 4.44 | - | Upgrade
|
| Buildings | 15.56 | - | 20.38 | 14.17 | - | - | Upgrade
|
| Machinery | 17.56 | - | 5.17 | 4.08 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.